Deals8 Apr 2025, 06:43 pm
Medicamen Biotech Signs Distribution Agreement for Three Products in European Market
AI Summary
Medicamen Biotech Ltd. has announced the signing of a Distribution Agreement with XGX Pharma, Denmark for three products in the European Market. The products include Temozolamide capsules and Bortezemib injection, both of which are oncology products, and Amoxicillin, oral dispersible tablets, which is a Beta-lactam product. Medicamen will hold the Marketing Authorization for these products. This is an update pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Medicamen Biotech has signed a Distribution Agreement with XGX Pharma, Denmark for three products in the European Market.
- The products include Temozolamide capsules and Bortezemib injection, both of which are oncology products, and Amoxicillin, oral dispersible tablets, which is a Beta-lactam product.
- Medicamen will hold the Marketing Authorization for these products.
- This deal is an update pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.